← SynDRA
IMD-0354
SynDRA canonical compound SYN0019068 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | IKBKB |
|---|
| Mechanism of action | IKK inhibitor | NFkB pathway inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- IKBKB INHIBITOR
- Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
- IKK inhibitor
- NFkB pathway inhibitor
Cross-references
Synonyms
- TCMDC-125465
- IMD-2560
- IMD-2560)
- I-kappaB kinase beta inhibitor (dermatological, atopic dermatitis/acne), Institute of Medicinal MolecularDesign
- I-kappaB kinase beta inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
- IKK-beta inhibitor (dermatological, atopic dermatitis/acne), IMMD
- IL-6 release inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
- BRD-K74305673
- IKK-2-inhibitor-V
- IMD0354
- RefChem:147935
- DTXCID50165739
- MFCD00218820
- C15H8ClF6NO2
- UNII-76145IS906
- Kinome_1864
- MLS006011200
- SCHEMBL129165
- orb1301039
- SCHEMBL29406220
- CHEBI:93310
- GLXC-06812
- HMS3229F11
- HMS3269F13
- HMS3413J21
- HMS3651D21
- HMS3677J21
- BDBM50430160
- EBC-70082
- IMD-0354?
- NSC800773
- NSC816638
- s2864
- AKOS017344958
- CCG-268447
- CS-4922
- NSC-800773
- NSC-816638
Look up IMD-0354 in the interactive SynDRA portal →